George Elston - Net Worth and Insider Trading

George Elston Net Worth

The estimated net worth of George Elston is at least $57,940 dollars as of 2024-11-06. George Elston is the CFO of EyePoint Pharmaceuticals Inc and owns about 4,000 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $46,440. George Elston is also the CFO of Juniper Pharmaceuticals Inc and owns about 1,000 shares of Juniper Pharmaceuticals Inc (JNP) stock worth over $11,500. Details can be seen in George Elston's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George Elston has not made any transactions after 2020-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of George Elston

To

George Elston Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, George Elston owns 3 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) , Juniper Pharmaceuticals Inc (JNP) , and Celldex Therapeutics Inc (CLDX) .

Click here to see the complete history of George Elston’s form 4 insider trades.

Insider Ownership Summary of George Elston

Ticker Comapny Transaction Date Type of Owner
EYPT EyePoint Pharmaceuticals Inc 2020-09-04 Chief Financial Officer
JNP Juniper Pharmaceuticals Inc 2016-08-31 Chief Financial Officer
CLDX Celldex Therapeutics Inc 2008-03-07 director

George Elston Latest Holdings Summary

George Elston currently owns a total of 2 stocks. Among these stocks, George Elston owns 4,000 shares of EyePoint Pharmaceuticals Inc (EYPT) as of September 4, 2020, with a value of $46,440 and a weighting of 80.15%. George Elston also owns 1,000 shares of Juniper Pharmaceuticals Inc (JNP) as of August 31, 2016, with a value of $11,500 and a weighting of 19.85%.

Latest Holdings of George Elston

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EYPT EyePoint Pharmaceuticals Inc 2020-09-04 4,000 11.61 46,440
JNP Juniper Pharmaceuticals Inc 2016-08-31 1,000 11.50 11,500

Holding Weightings of George Elston


George Elston Form 4 Trading Tracker

According to the SEC Form 4 filings, George Elston has made a total of 4 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in EyePoint Pharmaceuticals Inc is the acquisition of 1,000 shares on September 4, 2020, which cost George Elston around $4,800.

According to the SEC Form 4 filings, George Elston has made a total of 0 transactions in Juniper Pharmaceuticals Inc (JNP) over the past 5 years. The most-recent trade in Juniper Pharmaceuticals Inc is the acquisition of 1,000 shares on August 31, 2016, which cost George Elston around $5,500.

Insider Trading History of George Elston

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

George Elston Trading Performance

GuruFocus tracks the stock performance after each of George Elston's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George Elston is -2.13%. GuruFocus also compares George Elston's trading performance to market benchmark return within the same time period. The performance of stocks bought by George Elston within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how George Elston's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of George Elston

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.88 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -4.12 LIMIT LIMIT LIMIT LIMIT LIMIT

George Elston Ownership Network

Ownership Network List of George Elston

No Data

Ownership Network Relation of George Elston

Insider Network Chart

George Elston Owned Company Details

What does EyePoint Pharmaceuticals Inc do?

Who are the key executives at EyePoint Pharmaceuticals Inc?

George Elston is the Chief Financial Officer of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include director & President and CEO Nancy Lurker , SVP & Chief Commercial Officer David Scott Jones , and Chief Medical Officer Dario A. Paggiarino .

EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary

Over the past 18 months, George Elston made no insider transaction in EyePoint Pharmaceuticals Inc (EYPT). Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net sale of 121,307 shares made by Dario A. Paggiarino , and a net purchase of 4,794,057 shares made by Cormorant Asset Management, Lp .

In summary, during the past 3 months, insiders sold 0 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 23,240 shares, with a net purchase of 23,240 shares. During the past 18 months, 4,229,811 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 4,817,297 shares were bought by its insiders, resulting in a net purchase of 587,486 shares.

EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

EyePoint Pharmaceuticals Inc Insider Transactions

No Available Data

George Elston Mailing Address

Above is the net worth, insider trading, and ownership report for George Elston. You might contact George Elston via mailing address: 124 Chatham Street, Chatham Nj 07928.